Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Immunitas Therapeutics
650 East Kendall Street, 2nd Fl
Cambridge, MA 02142
https://www.immunitastx.com/

Immunitas Therapeutics, founded by Longwood Fund, employs a single cell genomics platform to dissect the biology of immune cells in human tumors, thereby advancing discoveries directly from the bench into meaningful clinical improvements. Our focus on human data allows us to start with and stay closer to the biology that is most relevant in patients and greatly accelerates the pace of our research. The Immunitas team of scientific pioneers innovates around each step of the drug development process, first identifying novel targets, then designing therapeutic strategies, and developing key biomarkers to guide the selection of patients who may benefit from our new drugs.

Key Contact
NameTitleE-Mail
Lea Hachigian, Ph.D.Co-Founder & President


Funding Events
DateAmountTypeInvestors
11/21/19$39,000,000Series A Alexandria Venture Investments
Evotec
Leaps by Bayer  
M Ventures
Novartis Venture Funds  
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.